Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07541989Not ApplicableActive Not Recruiting

Pulsed-Field Ablation With/Without Electrogram Mapping

Role: lead

NCT07153718Not ApplicableActive Not Recruiting

Optimal Ablation Strategies for Persistent AF With HF

Role: lead

NCT06729866Not ApplicableActive Not Recruiting

EGM Guided PFA for PerAF

Role: lead

NCT06947590Not ApplicableActive Not Recruiting

Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy

Role: lead

NCT06892808Not ApplicableActive Not Recruiting

Impact of Periodontal Therapy on AF Recurrence Post-Ablation in High-Inflammatory Burden Patients

Role: lead

NCT06740786Not ApplicableNot Yet Recruiting

Efficacy and Safety of Dapagliflozin in Preventing Atrial Fibrillation Recurrence After Catheter Ablation

Role: lead

NCT05883722Not ApplicableUnknown

Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation

Role: lead

All 7 trials loaded